top of page
Biosciences
Offspring
Insights & Updates
Surviving the Phase II Cliff: Why So Many Promising Drugs Fail — and What We Can Do About It
For translational leaders, generating decision-quality data before risking millions in clinical trials is crucial. De-Risk Antibody Development with Tissue Insights Platform.
Featured
Search
Ringing in 2026 with Exciting Projects and a New Look for Our Website
Looking ahead, we're energized by the pioneering work being done at every level of translational science, both here at Offspring and beyond.
Offspring Biosciences
Dec 25, 20252 min read
Offspring Biosciences Appoints Åsa Johansson as CEO to Drive Next Phase of Growth and Innovation
Åsa Johansson, CEO "We are thrilled to announce a significant leadership transition at Offspring Biosciences, marking an exciting new chapter for our company. Effective January 1st, 2025, Åsa Johansson will be stepping into the role of Chief Executive Officer (CEO), succeeding Anders Dahlstrand in this position.” T his change in leadership comes as Anders Dahlstrand, our former CEO, refocuses his role to leverage his deep expertise in business and science development. This st
Offspring Biosciences
Jan 31, 20252 min read
How Life Science Companies Can Receive Support In Their Work
Offspring Biosciences offers support services for businesses in preclinical and clinical drug development. – We help our customers make new drugs available to patients faster, safer, and at a lower cost, says Anders Dahlstrand, CEO of the company. Offspring Biosciences operates in the rapidly growing CRO industry (Contract Research Organization) and assists pharmaceutical and biotech companies by conducting preclinical and clinical studies required for regulatory approvals. O
Offspring Biosciences
Feb 9, 20242 min read
bottom of page